This fall Blue Horizon Charitable Foundation hosted its seventh annual Recognition Gala on Friday, October 19 at the iconic Manhattan Penthouse on Fifth Avenue in New York City.
“Tonight, as we gather together in this amazing space, it is important to recognize our mission. As a recognized 501 (c) (3) organization, we are dedicated to the research and development of stem-cell therapies to treat and manage diseases. This year, we are especially proud of supporting BHI Therapeutic Sciences’ Investigational New Drug application to proceed with clinical trial for acute ischemic stroke, which was recently FDA approved,” said BHCF’s Chairman, Orthopedic Trauma Surgeon Brian Mehling, M.D.
The beautiful evening included entertainment, fine dining, extraordinary company and incredible views of the nighttime cityscape and skyline.
“We want to thank everyone who has partnered with us on our journey to help people across the globe. For without you, our organization would not be able to provide the resources, raise the awareness, or provide the treatments that have touched and changed so many lives,” said Eddie Amarante, Co-Founder of BHCF.
BHI Therapeutic Sciences is a life sciences pioneer that brings advanced research, cutting-edge technology, innovative treatments, medical infrastructure, quality control, education and training to doctors, nurses, and other medical personnel throughout the world. Developing high quality healthcare centers in emerging markets provides an economic stimulus to local regions by creating medical tourism hubs, which will allow these markets to become viable and self-sustaining communities.
The Blue Horizon Charitable Foundation raises capital to help our organization change the landscape of healthcare delivery, especially in emerging markets. Our focus in on quality first, research, know-how, proven protocols, and ethically gathered placental and cord stem cells. We collaborate with national public health and economic development ministries, social-venture capital, local medical facilities, and entrepreneurs who can support our vision of bringing advanced clinics to a wider audience across the globe.